Noruega Crown Princess Mette-Marit has been added to the waiting list for a lung transplant. Norwegian Casa Real released the statement this Friday, June 5th. The measure comes after a further worsening of pulmonary fibrosis diagnosed in 2018. Aos 52 years old, she faces a chronic condition that causes scars in the lungs and compromises oxygen absorption.
Médicos of Hospital Universitário of Oslo consider the necessary procedure as short as possible. The official statement highlights that recent tests confirmed the progress of the disease.
Recent Piora led to medical decision
Experts have been monitoring the princess’s health for months. Last December, the hospital already signaled that the transplant was approaching, but she was not yet on the official list of recipients in Noruega.
Progressive pulmonary fibrosis gradually reduces respiratory capacity. Mette-Marit has significantly reduced her public schedule since late 2025 to focus on treatments and rehabilitation. Mesmo with limitations, she participated in some important ceremonies, such as the Dia Nacional celebrations in May.
Impacto on the royal family’s agenda
Crown prince Haakon is expected to reduce international travel in the coming months. The couple postponed their 25th wedding anniversary celebrations. The couple’s children, including Princess Ingrid Alexandra, who returned from engagements abroad, remain close to their mother.
Casa Real asked for privacy for the family during this period. Mette-Marit has always been open about the challenges of chronic illness since her initial diagnosis.
- The princess suspended official commitments to prioritize lung recovery
- Haakon adjusts schedule to monitor his wife’s treatment
- Filhos reinforces presence with the family
- Equipe doctor prepares conditions for the procedure
- Casa Real monitors the daily evolution of the condition
Lung Fibrose affects routine since 2018
The diagnosis became public in October 2018. At the time, the princess described the disease as rare and unpredictable. Ela lives with symptoms that require constant care, including respiratory support in times of greatest difficulty.
Over the years, Mette-Marit has balanced real obligations with periods of absence. Médicos of Rikshospitalet follows the case closely. Professor Are Holm, from the department of respiratory medicine, reinforced that the transplant aims to guarantee quality of life given the observed progression.
The Norwegian waiting list for lung transplants usually has between 20 and 40 patients, according to historical data. Waiting time varies depending on compatibility and clinical urgency.
Detalhes from the official statement
The text released by Casa Real is brief and direct. Ele mentions exhaustive evaluation and joint decision-making with the medical team. Não there is a scheduled date for the procedure, which depends on the availability of a compatible organ.
Mette-Marit continues to be monitored in Hospital Universitário by Oslo. The current focus is to stabilize the condition until surgery.
Repercussão on Noruega and abroad
The news mobilizes Norwegian public opinion, which has been following the health of the future queen consort for years. Muitos highlight the princess’s transparency about chronic conditions, which helped raise awareness about pulmonary fibrosis.
At the international level, vehicles follow development. The Norwegian royal family maintains a tradition of factual communication on health topics.
The condition requires multidisciplinary care. Lung Reabilitação, medications and daily adjustments are part of the routine. Transplantation represents a critical step in containing the progression of the disease.
Preparativos doctors in progress
Especialistas prepare the ground for the procedure. Additional Exames evaluate the princess’s general condition for the postoperative period. Lung transplant surgery is complex and requires a long recovery.
Casa Real did not report any immediate changes to the line of succession. Prince Haakon continues to fulfill essential commitments, with specific adjustments.
Mette-Marit has demonstrated resilience in recent appearances, even with occasional respiratory support. The decision to enter the list reflects medical consensus on the need for more definitive intervention.
